Antiproteinuric Effect of Imidapril Versus Ramipril in Type 2 Diabetic and Hypertensive Patients With Microalbuminuria

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 206 participants.

Also called NCT01230034

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 206 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01230034
  • EudraCT 2010-023332-17
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01230034. Randomized; no masking; primary purpose treatment. Start 2010-10 (registry gives no type); primary completion 2011-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Antiproteinuric Effect of Imidapril Versus Ramipril in Type 2 Diabetic and Hypertensive Patients With Microalbuminuria
Condition
Hypertension
Condition
Type 2 Diabetes Mellitus
Condition
Microalbuminuria
Intervention (Drug)
Ramipril
Intervention (Drug)
Imidapril
Lead sponsor
University of Pavia (class: other)

Record details

Record id
cardio:ct-nct01230034
Content hash
119c3801bc76e6d44405e7ce475b36d27fd41890b735d12eb8d844edcf899bd6